CYCLOSPORINE THERAPY FOR AUTOIMMUNE-DISEASE

被引：61

作者：

FATHMAN, CG

MYERS, BD

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1992年 / 326卷 / 25期

关键词：

D O I：

10.1056/NEJM199206183262509

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1693 / 1695

页数：3

共 10 条

[1] LIMITED DURATION OF REMISSION OF INSULIN DEPENDENCY IN CHILDREN WITH RECENT OVERT TYPE-I DIABETES TREATED WITH LOW-DOSE CYCLOSPORINE [J].

BOUGNERES, PF ;

LANDAIS, P ;

BOISSON, C ;

CAREL, JC ;

FRAMENT, N ;

BOITARD, C ;

CHAUSSAIN, JL ;

BACH, JF .

DIABETES, 1990, 39 (10) :1264-1272

[2] CYCLOSPORINE FOR PLAQUE-TYPE PSORIASIS - RESULTS OF A MULTIDOSE, DOUBLE-BLIND TRIAL [J].

ELLIS, CN ;

FRADIN, MS ;

MESSANA, JM ;

BROWN, MD ;

SIEGEL, MT ;

HARTLEY, AH ;

ROCHER, LL ;

WHEELER, S ;

HAMILTON, TA ;

PARISH, TG ;

ELLISMADU, M ;

DUELL, E ;

ANNESLEY, TM ;

COOPER, KD ;

VOORHEES, JJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (05) :277-284

[3] RISK-FACTORS FOR CYCLOSPORINE-INDUCED NEPHROPATHY IN PATIENTS WITH AUTOIMMUNE-DISEASES [J].

FEUTREN, G ;

MIHATSCH, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (25) :1654-1660

[4]

MASUDA K, 1989, LANCET, V1, P1093

[5] THE LONG-TERM COURSE OF CYCLOSPORINE-ASSOCIATED CHRONIC NEPHROPATHY [J].

MYERS, BD ;

SIBLEY, R ;

NEWTON, L ;

TOMLANOVICH, SJ ;

BOSHKOS, C ;

STINSON, E ;

LUETSCHER, JA ;

WHITNEY, DJ ;

KRASNY, D ;

COPLON, NS ;

PERLROTH, MG .

KIDNEY INTERNATIONAL, 1988, 33 (02) :590-600

[6]

MYERS BD, 1991, J AM SOC NEPHROL, V2, pS45

[7]

SHEVACH EM, 1985, ANNU REV IMMUNOL, V3, P397

[8] CYCLOSPORINE-A, FK-506, AND RAPAMYCIN - PHARMACOLOGICAL PROBES OF LYMPHOCYTE SIGNAL TRANSDUCTION [J].

SIGAL, NH ;

DUMONT, FJ .

ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 :519-560

[9] LOW-DOSE CYCLOSPORINE VERSUS PLACEBO IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

TUGWELL, P ;

BOMBARDIER, C ;

GENT, M ;

BENNETT, KJ ;

BENSEN, WG ;

CARETTE, S ;

CHALMERS, A ;

ESDAILE, JM ;

KLINKHOFF, AV ;

KRAAG, GR ;

LUDWIN, D ;

ROBERTS, RS .

LANCET, 1990, 335 (8697) :1051-1055

[10]

ZIEGLER AG, 1989, IMMUNOTHERAPY TYPE 1, P155

← 1 →